The Europe Forensic Genomics Market should witness market growth of 14.2% CAGR during the forecast period (2022-2028).
The capacity of next-generation sequencing to enable human identification using deteriorated blood samples, as well as its application in paternity testing, has caused a major increase in its usage. The precision of next-generation sequencing significantly lessens bias and errors. Rising investment and several biometrics-related projects to improve cybersecurity and efficiently handle forensic data provided by intelligence agencies have further increased the application of NGS.
Technology advancements are increasing test accuracy while lowering overall expenses. Forensic genomics is seeing a surge in demand for tests and applications that are more accurate and efficient as a result of the development of more cutting-edge technologies. Higher use of these techniques across government and corporate agencies is another outcome of greater and improved accuracy.
Cybercrimes and online fraud are on the rise as a result of improvements in Internet technology for digital data movement, communications, and storage of sensitive data. Another element that uses forensic genomics immensely is the rise in identity theft cases and unauthorized use of debit/credit card information.
In this region, the future of forensic genomics is being investigated through the research project CRIMTYP (CRIMinal Forensic Genomics PhenoTYPing). The University of Luxembourg's academic departments, law enforcement organizations, and private and public actors in the domain of genomics and next-generation sequencing are included in the initiative. With the development of new techniques, there are more options to use heritable phenotypic alterations and forensic DNA phenotyping (FDP), which estimates the externally evident traits of a person whose DNA was collected from the crime scene.
The Germany market dominated the Europe Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $67.3 Million by 2028. The UK market is anticipated to grow at a CAGR of 13.3% during (2022-2028). Additionally, The France market would exhibit a CAGR of 15% during (2022-2028).
Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.
The capacity of next-generation sequencing to enable human identification using deteriorated blood samples, as well as its application in paternity testing, has caused a major increase in its usage. The precision of next-generation sequencing significantly lessens bias and errors. Rising investment and several biometrics-related projects to improve cybersecurity and efficiently handle forensic data provided by intelligence agencies have further increased the application of NGS.
Technology advancements are increasing test accuracy while lowering overall expenses. Forensic genomics is seeing a surge in demand for tests and applications that are more accurate and efficient as a result of the development of more cutting-edge technologies. Higher use of these techniques across government and corporate agencies is another outcome of greater and improved accuracy.
Cybercrimes and online fraud are on the rise as a result of improvements in Internet technology for digital data movement, communications, and storage of sensitive data. Another element that uses forensic genomics immensely is the rise in identity theft cases and unauthorized use of debit/credit card information.
In this region, the future of forensic genomics is being investigated through the research project CRIMTYP (CRIMinal Forensic Genomics PhenoTYPing). The University of Luxembourg's academic departments, law enforcement organizations, and private and public actors in the domain of genomics and next-generation sequencing are included in the initiative. With the development of new techniques, there are more options to use heritable phenotypic alterations and forensic DNA phenotyping (FDP), which estimates the externally evident traits of a person whose DNA was collected from the crime scene.
The Germany market dominated the Europe Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $67.3 Million by 2028. The UK market is anticipated to grow at a CAGR of 13.3% during (2022-2028). Additionally, The France market would exhibit a CAGR of 15% during (2022-2028).
Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.
Scope of the Study
By Application
- Criminal Testing
- Paternity & Familial Testing
- Others
By Product
- Kits & Consumables
- Analyzers & Sequencers
- Software
By Method
- Capillary Electrophoresis
- Next-generation Sequencing
- PCR Amplification
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Eurofins Scientific Group (Eurofins Discovery)
- Gene by Gene, Ltd.
- Verogen, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Neogen Corporation
- Thermo Fisher Scientific, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Forensic Genomics Market by Application
Chapter 5. Europe Forensic Genomics Market by Product
Chapter 6. Europe Forensic Genomics Market by Method
Chapter 7. Europe Forensic Genomics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Eurofins Scientific Group (Eurofins Discovery)
- Gene by Gene, Ltd.
- Verogen, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Neogen Corporation
- Thermo Fisher Scientific, Inc.
Methodology
LOADING...
